Cardiac biomarkers for assessment of acute coronary syndrome <b>[Abstract in English]<\b>
Keywords:
ACUTE CORONARY SYNDROME/diagnosis, CORONARY DISEASE, NECROSIS, INFLAMMATION, MYOCARDIAL ISCHEMIA/diagnosis, ATHEROSCLEROSIS, MYOCARDIAL INFARCTION, BIOLOGICAL MARKERS.Abstract
Aims: To address the use of cardiac biomarkers associated with necrosis, inflammation, plaque destabilization, and cardiac ischemia in the evaluation of acute coronary syndrome in order to provide a better understanding of the advantages and disadvantages of the clinical use of these biomarkers. Source of data: Scientific original and review articles from the PubMed and SciELO databases. Summary of findings: Cardiovascular diseases, especially acute coronary syndrome, are the leading cause of mortality in Brazil and worldwide, and its continued growth is one of public health issues most relevant today. In this sense, the cardiac biomarkers are key to the diagnosis of acute coronary syndrome, and the cardiac troponins are still considered the gold standard for its diagnosis. With the recent development of ultra-sensitive methods for measuring cardiac troponins, it has been possible to detect heart damage within two hours, substantially improving the early diagnosis of acute myocardial infarction. Other biomarkers have been showing relevance, especially in relation to prognosis and risk stratification of patients with ischemic heart disease. Conclusions: Several biomarkers have shown efficacy in the detection of necrosis, ischemia, inflammation, plaque destabilization and cardiac dysfunction. However, cardiac troponins are still considered the gold standard for diagnosis of acute myocardial infarction.Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright
The submission of originals to Scientia Medica implies the transfer by the authors of the right for publication. Authors retain copyright and grant the journal right of first publication. If the authors wish to include the same data into another publication, they must cite Scientia Medica as the site of original publication.
Creative Commons License
Except where otherwise specified, material published in this journal is licensed under a Creative Commons Attribution 4.0 International license, which allows unrestricted use, distribution and reproduction in any medium, provided the original publication is correctly cited.